Empyrean Therapeutics, Inc. | WebDisclosure

Basculer en Français

8402	Companies
122494	Keywords
60929	Articles
65768	Press releases

Headlines Articles Press releases Empyrean Therapeutics, Inc.

Home
Companies
Empyrean Therapeutics, Inc.

BRIEF

published on 11/25/2024 at 23:25, 1 month 1 day ago

Empyrean Therapeutics Acquires Novel Cancer Treatment Molecule

Cancer Treatment Pharmaceutical Acquisition Empyrean Therapeutics TLR-2 Antagonist R&D Innovation
BRIEF

published on 11/25/2024 at 23:25, 1 month 1 day ago

Empyrean Therapeutics acquiert une nouvelle molécule pour le traitement du cancer

Traitement Du Cancer Acquisition Pharmaceutique Thérapeutique Empyrean Antagoniste Du TLR-2 Innovation En R&D
PRESS RELEASE

published on 11/25/2024 at 23:20, 1 month 1 day ago

Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment
Empyrean Therapeutics, Inc. acquires novel cancer drug molecule EMS-312 from Eos Therapies, aiming to expedite development for brain, pancreatic, breast, and hard-to-treat cancers. Strategic move marks milestone. CEOs Kal Fishman and Doug Bonhaus express optimism

Empyrean Therapeutics Novel Cancer Drug EMS-312 Eos Therapies CEO Kal Fishman

Accesswire

Published on 12/26/2024 at 21:20, 5 hours 55 minutes ago

Valsoft Corporation obtient 150 M$ pour accélérer sa croissance dans le secteur des logiciels de marchés verticaux
Published on 12/26/2024 at 21:20, 5 hours 55 minutes ago

Valsoft Corporation Secures $150M to Further Accelerate Growth in Vertical Market Software Sector
Published on 12/26/2024 at 20:00, 7 hours 15 minutes ago

Breaking Update - BOI Reporting is Back: New Filing Deadline Set for January 13, 2025
Published on 12/26/2024 at 14:30, 12 hours 45 minutes ago

Network-1 Commences Patent Litigation against Citadel Securities and Jump Trading
Published on 12/26/2024 at 13:15, 14 hours ago

SMX Integrates Its Proprietary Coating and Digital Platform Technology for NFC & RFID Chip Markings and Protection

View all ACCESSWIRE

EQS Group

Published on 12/26/2024 at 17:45, 9 hours 30 minutes ago

REALITES : calendrier financier du premier semestre 2025
Published on 12/26/2024 at 15:09, 12 hours 6 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 12/26/2024 at 15:08, 12 hours 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Published on 12/26/2024 at 15:06, 12 hours 9 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Published on 12/26/2024 at 15:05, 12 hours 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc

Les Echos

Published on 12/24/2024 at 20:11, 2 days 7 hours ago

Déclaration des transactions sur actions propres réalisées du 16 au 20 décembre 2024
Published on 12/24/2024 at 20:11, 2 days 7 hours ago

Disclosure of trading in own shares between December 16th and December 20th, 2024
Published on 12/24/2024 at 20:06, 2 days 7 hours ago

Déclaration des transactions sur actions propres réalisées du 9 au 13 décembre 2024
Published on 12/24/2024 at 20:06, 2 days 7 hours ago

Disclosure of trading in own shares between December 9th and December 13th, 2024
Published on 12/24/2024 at 08:32, 2 days 18 hours ago

Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 16/12/2024 tot 20/12/2024

View all LES ECHOS COMFI WIRE